Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

Google-Backed Gene Editing Startup Files for $100M IPO

January 7, 2016 9:05 am | by Ryan Bushey, Associate Editor | News | Comments

The Cambridge, Massachusetts-based startup would become the first publicly-traded company specializing in gene editing. Read more....


Study: Ebola Survivors' Blood Didn't Help Patients in Guinea

January 7, 2016 8:42 am | by Maria Cheng, AP Medical Writer | News | Comments

At a clinic in the capital Conakry, scientists found no difference in survival between 84 patients who got survivor blood compared to about 400 patients treated some five months earlier. Read more...


Using Nanoparticles to Combat Arteriosclerosis

January 7, 2016 8:39 am | by University of Bonn | News | Comments

The researchers tested this combination method in mice whose carotid artery endothelial cells were injured. Read more...


Valeant Names Howard Schiller as Interim CEO

January 7, 2016 8:33 am | by Tom Murphy, AP Business Writer | News | Comments

Valeant Pharmaceuticals has named former finance chief Howard Schiller as interim CEO. Read more...

Sanofi Severs Marketing Partnership with Inhaled Insulin Maker Mannkind

January 7, 2016 8:33 am | by Ryan Bushey, Associate Editor | News | Comments

There were high hopes for Afreeza during the development process. Read more...


MRSA Treatment Market to See Minimal Growth Despite Opportunities for New Entrants

January 7, 2016 8:32 am | by Christopher J. Pace, Ph.D., GlobalData Managing Analyst, Infectious Diseases | News | Comments

Opportunities within the market are rife, even with its ostensible homogeneity. Read more...


Actelion: PAH Drug Could Cost $160,000 to $170,000 in U.S.

January 7, 2016 8:32 am | by Ryan Bushey, Associate Editor | News | Comments

PAH is a form of high blood pressure that makes pulmonary arteries and capillaries in the lungs become narrowed or blocked. Read more...


Study Finds No Increased Risk of Autism, ADHD with Prenatal Antidepressant Exposure

January 6, 2016 9:48 am | by Massachusetts General Hospital | News | Comments

An analysis of medical records data from three Massachusetts health care systems finds no evidence that prenatal exposure to antidepressants increases the risk for autism and related disorders or for attention-deficit hyperactivity disorder (ADHD). Read more...


New Proteomics Tools to Open Up Drug Discovery

January 6, 2016 9:15 am | by Dr. Paul Ko Ferrigno, Chief Scientific Officer, and Dr. Jane McLeod, of Avacta Life Sciences | Articles | Comments

In the current genomic era of very accurate DNA analyses by in situ hybridization, DNA chip analyses, and deep sequencing, it is often assumed that antibodies have an analogous ability to identify molecular targets accurately. Nothing could be further from the truth. Read more...


Sounding the Alarm on a Future Epidemic: Alzheimer's Disease

January 6, 2016 9:13 am | by UCLA | News | Comments

We’re living longer. The number of U.S. adults 65 and older — roughly 40 million as of the 2010 census — is expected to nearly double to 71 million by 2030 and to reach 98 million by 2060. In much of the rest of the world, the story is the same. Read more...


Chimerix Antiviral Drug Fails in Late-Stage Study

January 6, 2016 8:52 am | by Amrutha Penumudi and Anjali Rao Koppala in Bengaluru, Reuters | News | Comments

Chimerix shares were down 72 percent in premarket trading. Read more...


'Moneyball' Statistician Joins Scripps Health Data Team

January 6, 2016 8:52 am | by Greg Watry, Digital Reporter | Articles | Comments

Paul DePodesta, the assistant general manager for the Oakland Athletics between 1998 and 2004, is bringing his statistical prowess to Scripps Translational Science Institute. Read more...


Simple Shell of Plant Virus Sparks Immune Response Against Cancer

January 6, 2016 8:35 am | by Case Western Reserve University | News | Comments

The scientists tested a 100-year-old idea called in-situ vaccination. Read more...


Express Scripts Releases Better-Than-Expected 2016 Forecast

January 6, 2016 8:34 am | by The Associated Press | News | Comments

Express Scripts is projecting 2016 earnings that surpass Wall Street expectations and affirmed earlier growth guidance for this year. Read more...


FDA Approves Zurampic to Treat High Blood Uric Acid Levels Associated with Gout

January 6, 2016 8:33 am | News | Comments

The U.S. Food and Drug Administration yesterday approved Zurampic (lesinurad) to treat high levels of uric acid in the blood (hyperuricemia) associated with gout, when used in combination with a xanthine oxidase inhibitor (XOI), a type of drug approved to reduce the production of uric acid in the body. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.